SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-020508
Filing Date
2018-08-08
Accepted
2018-08-08 16:24:16
Documents
64
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q achv-10q_20180630.htm 10-Q 1401757
2 EX-31.1 achv-ex311_7.htm EX-31.1 9049
3 EX-31.2 achv-ex312_10.htm EX-31.2 9087
4 EX-32.1 achv-ex321_8.htm EX-32.1 4839
5 EX-32.2 achv-ex322_9.htm EX-32.2 4860
  Complete submission text file 0001564590-18-020508.txt   5877725

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT achv-20180630.xml EX-101.INS 1119597
7 XBRL TAXONOMY EXTENSION SCHEMA achv-20180630.xsd EX-101.SCH 57048
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE achv-20180630_cal.xml EX-101.CAL 50182
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE achv-20180630_def.xml EX-101.DEF 227668
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE achv-20180630_lab.xml EX-101.LAB 419310
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE achv-20180630_pre.xml EX-101.PRE 340442
Mailing Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101
Business Address 520 PIKE STREET SUITE 2250 SEATTLE WA 98101 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 033-80623 | Film No.: 181001698
SIC: 2835 In Vitro & In Vivo Diagnostic Substances